General Information of the Protein
| Protein ID |
PT05058
|
||||
|---|---|---|---|---|---|
| Protein Name |
Interleukin-1 beta
|
||||
| Secondarily Protein Name |
Catabolin
|
||||
| Gene Name |
IL1B
|
||||
| Secondarily Gene Name |
IL1F2
|
||||
| Sequence |
MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Secreted protein
|
||||
| Function |
Potent pro-inflammatory cytokine (PubMed:3920526, PubMed:10653850, PubMed:12794819, PubMed:28331908). Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production (PubMed:3920526). Promotes Th17 differentiation of T-cells. Synergizes with IL12/interleukin-12 to induce IFNG synthesis from T-helper 1 (Th1) cells (PubMed:10653850). Plays a role in angiogenesis by inducing VEGF production synergistically with TNF and IL6 (PubMed:12794819). Involved in transduction of inflammation downstream of pyroptosis: its mature form is specifically released in the extracellular milieu by passing through the gasdermin-D (GSDMD) pore (PubMed:33377178, PubMed:33883744). Acts as a sensor of S.pyogenes infection in skin: cleaved and activated by pyogenes SpeB protease, leading to an inflammatory response that prevents bacterial growth during invasive skin infection (PubMed:28331908).
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| HGNC ID | |||||
| Subcellular Location |
Cytoplasm
Cytosol
Secreted
Lysosome
Secreted
Extracellular exosome
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000040 , THP-1
Clinical Information about the Protein
Target 1 ( Interleukin-1 beta (IL1B) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 2 Target-related Diseases | 2 | |||
| 1 | Osteoarthritis [ICD-11: FA00-FA05] | ||||
| 2 | Motor neurone disease [ICD-11: 8B60] | ||||
| Approved Drug(s) | 1 Approved Drug | 1 | |||
| 1 | Glucosamine | Approved | |||
| Preclinical Drug(s) | 1 Preclinical Drug | 1 | |||
| 1 | Celastrol | Preclinical | |||
Target 2 ( HUMAN interleukin-1 beta (IL1B) )
| Target Type | Unknown Type Target | ||||
|---|---|---|---|---|---|